Since 1985, the International Gynecologic Cancer Society (IGCS) has been uniting the globe in the fight against gynecologic cancer by contributing to the prevention, treatment and study of gynecologic cancer, as well as improvement in the quality of life among women suffering from gynecologic cancer throughout the world.
IGCS shares knowledge to establish high standards and raise public awareness for detection and treatment of women’s cancer. Learn More
Advocacy & EngagementShort subtitle here
IGCS members advocate on behalf of patients to empower and protect their interests and strive to provide patients access to available resources. Learn More
Global Curriculum and Mentorship ProgramShort subtitle here
To enhance the care of women with gynecologic cancer worldwide through education, training, and public awareness. Learn More
Travel Funding Opportunities Short subtitle here
Alliances with organizations whose goals align with those of the IGCS strengthen our message and broaden the reach of our mission. Learn More
Gynecologic Oncology Cancer Care Unit Certificate ProgramShort subtitle here
IGCS membership includes experts in women’s cancer care from around the world. Learn More
Online EducationShort subtitle here
Our members are valuable resources that facilitate professional connections on a global scale to share knowledge to improve the lives of women with cancer. Learn More
Early Career Research & PublicationsShort subtitle here
Visiting Scholar & Mentorship Program
The IGCS International Visiting Scholar & Mentorship Program has returned! Training Gynecologic Oncologists around the world to care for women with gynecologic malignancies is challenging. Many regions, particularly in low and middle-income countries (LMICs), do not have formal fellowship training in gynecologic oncology and those with formal training often do not have opportunities to learn new treatments and procedures. While an increasing number of countries are prioritizing the need for structured training programs, it takes time, commitment and resources to develop the infrastructure needed to support such a curriculum. In response to the global need for training and mentorship in the field of gynecologic oncology, the IGCS Council has decided to re-establish the IGCS International Visiting Scholar & Mentorship Program (formerly known as the Traveling Scholars Program). Dr. Vivek Arora (Australia), Member of the IGCS Council and Mentorship & Training Committee, has led the charge in developing objectives and establishing the scope of the new and improved program. Dr. Arora says: “There still exists a wide disparity in access to care for women suffering from gynaecological cancer in different parts of the world. This program is yet another effort that will complement the existing initiatives of the International Gynecological Cancer Society in bridging this gap. The aim of this program is to foster long term mentoring relationships.” The Traveling Scholars
Gynecologic Oncology News & Updates
A compilation of news articles in the field of gynecologic oncology and recent scientific studies Ultrasonography useful for predicting ovarian-cancer risk November 16, 2018: MD Linx – The ultrasonographic appearance of ovarian masses is strongly associated with a woman’s risk of ovarian cancer, researchers report. Read more. Olaparib Suitable For Long-term Maintenance in Recurrent Ovarian Cancer November 13, 2018: Targeted Oncology – The side effect profile of olaparib tablets and the low rate of treatment discontinuation make it suitable for maintenance treatment for patients with platinum-sensitive recurrent ovarian cancer, according to safety assessments from the SOLO-2 trial. Read more. FDA grants priority review to Lynparza for maintenance therapy of BRCA-positive ovarian cancer November 12, 2018: Healio – The FDA granted priority review to a supplemental new drug application that seeks approval of olaparib tablets for maintenance therapy of women with newly diagnosed BRCA-mutated advanced ovarian cancer. Read more. Moore Reflects on Pivotal PARP Data in Ovarian Cancer November 9, 2018: Targeted Oncology – Promising data with PARP inhibitors, specifically olaparib (Lynparza) and niraparib (Zejula), are showcasing this class of agents’ activity in early and later-line settings of ovarian cancer, explained Kathleen Moore, MD. Read more. Saving Costs While Maintaining Quality of Care—The Value of Biosimilars in Oncology November 8, 2018: AJMC – According to a review published in Cancer Management and Research, biosimilar products present a
The New Scientific Program Committee
Dear Colleagues, It was a great pleasure to see so many of you in Kyoto last month. Congratulations to everyone involved in making the meeting such a great success with over 3,100 in attendance. This was the last meeting for the IGCS that occurs in a biennial pattern; IGCS 2019 will be the first Annual Global Meeting being held in Rio de Janeiro Sept. 19-21, 2019. IGCS continues to grow (with over 2,650 members) and evolve in many ways to achieve our goal to become a society that truly represents its international membership. The Annual Global Meeting is no exception. We are very fortunate to have Nadeem Abu-Rustum from Memorial Sloan Kettering in New York as the chair of our inaugural Annual Global Meeting. The IGCS Scientific Program Committee has been restructured in a way that provides an equal opportunity for contribution from all regions of the world. The committee has been expanded to include Regional Chairs that represent five global regions: Latin America, Europe, Africa/Middle East, USA/Canada, and Asia/Australia. Each Regional Chair has asked additional members from their region to assist in identifying trends, issues, opportunities and challenges facing their region along with encouraging submission of important science for peer review. The 2019 Scientific Program Committee recently met to discuss the new committee structure and how the committee can work
Join us for IGCS 2019 which will be held in the vibrant and dynamic city of Rio de Janeiro, Brazil on September 19 – 21 2019! Abstract Submission: October 30 2018 – April 1, 2019 Learn more at www.igcs2019.com.
2019 Membership Renewal
Please Submit Membership Dues by December 31, 2018 Thank you for being a valued member of the IGCS. The society relies on the strength of your membership to remain an active, vital part of the global gynecologic cancer community. We are currently renewing for the 2019 membership year: January 1, 2019-December 31, 2019. All individual Full Memberships are scheduled to expire on December 31, 2019. To continue your member benefits and uninterrupted online access to the International Journal of Gynecological Cancer, please log in here: https://igcs.org/member-dues, and submit your dues payment. While you are logged in, please take a moment to review your profile to verify that your contact and demographic information is current. The preferred method of payment is online by credit card. However, if you wish to mail a check or money order or require additional documentation, please email firstname.lastname@example.org. If you have technical problems with the IGCS website, email email@example.com. IGCS values your participation and commitment to the society. We thank you for your continuing membership.